Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
In-hospital Medical Therapy Initiation/Titration
Author(s): Zachary L Cox , Shuktika Nandkeolyar , Andrew J Johnson , et al Added: 1 year ago

Heart Failure
In Cardiogenic Shock, Age is Not Just a Number
Author(s): Aniket S Rali , Lena Tran , Malcolm Dix , et al Added: 3 weeks ago

Heart Failure
ESC 23: Economic Burden of CVD in the EU
Author(s): Ramón Luengo-Fernández Added: 7 months ago
ESC 2023 — Dr Ramón Luengo-Fernández (University of Oxford, UK) joins us on-site to discuss the findings from a registry which aimed to analyse the economic burden of cardiovascular disease within the EU. This was the first study to utilise Europe-wide patient registries and included the costs of long-term social care. Results from the registry found that cardiovascular disease cost the EU €282… View more

Standards & Guidelines
Role of Cardiac Troponin Levels in Acute Heart Failure
Author(s): Nicholas Wettersten , Alan S Maisel Added: 3 years ago
Cardiac troponin (cTn) is the core biomarker for the diagnosis of a myocardial infarct (MI).1 Indeed, as stated in Table 1, it meets all the definitions of a biomarker for acute coronary syndrome (ACS), as suggested by Maisel.2 In the setting of ACS, in addition to its diagnostic use, it is prognostic, clinically actionable and can be monitored during therapy as a surrogate of improvement. In… View more

Heart Failure

MI/ACS
HF 22: DELIVER Extends Benefits of Dapagliflozin to the Full Spectrum of Pt
Author(s): Scott Solomon Added: 1 year ago
In this short interview, Dr Scott Solomon (Brigham And Women's Hospital & Harvard Medical School, Boston, MA, US) discusses the design and baseline of the DELIVER trial. This trial was designed to evaluate the effects of the dapagliflozin on cardiovascular death, heart failure (HF) hospitalization, or urgent HF visits in patients with HF with mildly reduced and preserved left ventricular ejection… View more

Heart Failure
ESC EORP HFA Heart Failure Long Term Registry
Author(s): Ovidiu Chioncel Added: 4 years ago
Prof Ovidiu Chioncel (University of Medicine Carol Davilla, Bucuresti, RO) discusses insights from theESC EORP HFA Heart Failure Long Term Registry –Acute heart failure congestion and perfusion status; impact of the clinical classification on in hospital and long-term outcomes. Filmed on site at HFA 2019 by Radcliffe Cardiology. Videographer: Mike Knight Interviewer: Liam O'Neill View more

Heart Failure
TAVR and SAVR Outcomes in LVAD Patients with AI
Author(s): Aniket S Rali , Siva Taduru , Lena E Tran , et al Added: 1 year ago

Heart Failure
Research Area(s) / Expertise: Job title: Professor
Marco Metra is Full Professor of Cardiology and Director of the Institute of Cardiology of the Civil Hospital and University of Brescia, Italy, and Editor-in-Chief of theEuropean Journal of Heart Failureand Senior Consulting Editor of theEuropean Heart Journal. Prof Metra has been principal investigator and member of the Executive or Steering Committees of many trials in patients with heart… View more
Author(s): Ovidiu Chioncel , Sean P Collins , Andrew P Ambrosy , et al Added: 3 years ago
Acute heart failure (AHF) is a heterogeneous clinical syndrome including diverse phenotypes sharing similar presenting signs and symptoms.1 The diversity of aetiologies and precipitants of HF and their specific pathophysiologic mechanisms, may result in distinct clinical profiles requiring specific treatment approaches. Pulmonary oedema (PO) is a common manifestation of AHF associated with a… View more

Heart Failure